Executive Summary
This digest covers a single, massive $48.06 billion contract awarded by the Department of Energy (DOE) to Lockheed Martin Corp. The contract is classified as non-defense (civilian), representing a dominant, long-term obligation that dwarfs typical DOE awards.
The bullish signal is strong given the sheer size and sole-source nature, but the lack of pricing details, competition context, and revenue estimates introduces significant uncertainty. The key risk is the absence of transparency around contract type (fixed-price vs. cost-plus) and Lockheed Martin's annual revenue exposure, which could imply execution risk or margin compression. Investors should monitor for follow-on task orders or modifications that clarify terms.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All DOE Contracts digest from May 10, 2026.
Investment Signals (1)
- Lockheed Martin Secures $48.06B DOE Contract – Largest Civilian Award in Period (MEDIUM)▲
Lockheed Martin Corp was awarded a $48.06 billion contract from the Department of Energy, the sole contract in this period and the highest materiality signal (8/10). This suggests deep entrenchment in DOE's nuclear or energy infrastructure portfolio, likely tied to management and operations of a major facility (e.g., National Nuclear Security Administration labs).
Risk Flags (2)
- Execution [HIGH RISK]▼
The contract's pricing model (fixed-price vs. cost-plus) is unknown, which is critical for Lockheed Martin's margin profile. A cost-plus structure could cap profitability, while fixed-price could expose the company to cost overruns on a $48B program. Additionally, the contract's age (awarded 1993) raises questions about modifications or extensions that may have altered terms.
- Concentration [CRITICAL RISK]▼
Lockheed Martin's reliance on this single DOE contract represents a massive concentration risk. If the contract faces budget cuts, protests, or performance issues, the revenue impact could be material given the $48B value relative to Lockheed's total revenue (~$70B annually).
Opportunities (1)
- ◆
While this is a civilian DOE contract, Lockheed Martin's deep relationship with DOE could serve as a bridge to adjacent defense programs, particularly in nuclear modernization (e.g., Sentinel ICBM, nuclear propulsion). The contract's longevity (since 1993) signals a trusted partnership that may facilitate cross-agency expansion.
Sector Themes (1)
- ◆
The $48B DOE contract to Lockheed Martin underscores how large civilian agency awards can have defense-adjacent implications, particularly in nuclear energy and national security. This blurs the line between pure defense and civilian contractors, creating opportunities for firms with dual-use capabilities.
Watch List (2)
- 👁
{"entity"=>"Lockheed Martin Corp", "reason"=>"The $48B DOE contract represents a significant but opaque revenue stream. Any modification, protest, or budget cut could materially impact Lockheed's financials.", "trigger"=>"DOE contract modification announcement or GAO protest filing"}
- 👁
{"entity"=>"Department of Energy", "reason"=>"DOE's budget trajectory and contract management practices will determine the durability of this award. A shift toward fixed-price contracts could pressure contractor margins.", "trigger"=>"FY2027 DOE budget request release (expected Feb 2026)"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All DOE Contracts
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals